Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q4 2014 · 10-K
Revenue$2.47M$2.47M−8.8% vs Q4 2013 Net Income-$5.76M-$5.76MN/M vs Q4 2013 EPS Diluted-$0.08-$0.08N/M vs Q4 2013 Gross Profit$1,053,000−33.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived-$4,956,000N/M Free Cash Flowderived-$4,928,000N/M Margins · derivedGross margin42.6%−15.7 pt vs Q4 2013
Operating margin-174.8%+162.2 pt vs Q4 2013
Net margin-233.1%+138.0 pt vs Q4 2013
ended Dec 31, 2014 · filed Mar 16, 2015 · 75 d after period end